Free Trial

Cibus Q4 2023 Earnings Report

Cibus logo
$2.48 +0.01 (+0.40%)
As of 01/17/2025 04:00 PM Eastern

Cibus EPS Results

Actual EPS
-$1.16
Consensus EPS
-$1.12
Beat/Miss
Missed by -$0.04
One Year Ago EPS
N/A

Cibus Revenue Results

Actual Revenue
$1.10 million
Expected Revenue
$0.27 million
Beat/Miss
Beat by +$830.00 thousand
YoY Revenue Growth
N/A

Cibus Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Cibus Earnings Headlines

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
See More Cibus Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cibus? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cibus and other key companies, straight to your email.

About Cibus

Cibus (NASDAQ:CBUS), a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.

View Cibus Profile

More Earnings Resources from MarketBeat